Dr. Paul Richardson from Dana-Farber Cancer Institute, and Dr. Sergio Giralt, from Memorial Sloan-Kettering Cancer Center both recently returned from the American Society of Clinical Oncology meeting in Chicago. They share the latest news, what they are excited about, and answer questions submitted by myeloma community. The expert guests are joined by Mike Katz, a savvy myeloma patient and leader of ACOR's myeloma online community. More interviews from the 2010 ASCO meeting can be found at www.patientpower.info/asco.
|
Paul Richardson, M.D.
Clinical Director, Jerome Lipper Center for Multiple Myeloma , Dana-Farber Cancer Institute
Dr. Richardson is Associate Professor of Medicine at Harvard Medical School, as well as Clinical Director of the Jerome Lipper Center for Multiple Myeloma at the Dana-Farber Cancer Institute in Boston and Chairman of the American Myeloma Research Consortiom. He received his medical degree from the Medical College of St. Bartholomew's Hospital, University of London, and completed residency training at...
more >
|
|
|
|
Mike Katz,
Myeloma patient and Leader of ACOR's Myeloma Online Community
Mike Katz is a savvy myeloma patient and leader of ACOR's myeloma online community.
more >
|
|
|
|
Sergio Giralt, M.D.
Chief, Attending Physician, Adult Blood and Marrow Transplant , Memorial Sloan-Kettering Cancer Center
Dr. Sergio Giralt attended Universidad Central de Venezuela as a medico cirujano. He received his medical degree from Universidad Central de Venezuela and completed his postgraduate internship at the University Hospital of Caracas. He completed an internal medicine residency at Good Samaritan Hospital in Cincinnati, Ohio and a postdoctoral fellowship in hematology oncology. Dr. Giralt, professor of medicine, joined the...
more >
|
|
|

